Found 5 articles for: "Medicare"
Reining in Medicare Spending on Skin Substitutes: What the 2026 Reforms Mean for Dermatology
August 2026 | Volume 25 | Issue 8 | Features | 756 | Copyright © August 2026
Disparities in Alopecia Areata and Vitiligo FDA-Approved Therapies in Medicaid Formularies
March 2025 | Volume 24 | Issue 3 | Editorials | e17 | Copyright © March 2025
Analysis of Utilization, Cost, and Prescription Trends of Common Immunosuppressive Medications Among Medicare Patients 2013 to 2019
April 2024 | Volume 23 | Issue 4 | Editorials | e113 | Copyright © April 2024
Annual Trends in Medicare Part D Prescription Claims for Dupilumab 2017 to 2019
October 2022 | Volume 21 | Issue 10 | Editorials | 1138 | Copyright © October 2022
Disease control for moderate to severe atopic dermatitis (AD) has been primarily achieved with phototherapy and non-specific immunomodulators, cyclosporine, and methotrexate. These treatments have, ho...
Read MoreUsage of Topical Calcineurin Inhibitors in the Medicare Population from 2013 to 2018
August 2022 | Volume 21 | Issue 8 | Editorials | 912 | Copyright © August 2022
Topical calcineurin inhibitors are a family of drugs that have been touted for having high efficacy without the risks of cutaneous atrophy and systemic absorption seen with topical corticosteroids. Th...
Read More
